The new FDA Adverse Event Monitoring System (AEMS) now lets patients and researchers easily search and analyze thousands of safety reports in one place for the first time, boosting transparency on all... View Post

The FDA has formally warned the manufacturer of the popular weight-loss and diabetes drugs for failing to report potential side effects, raising new questions about long-term safety monitoring. 🔗... View Post